These results suggest activation PGC-1α regulated the VEGF/VEGFR2 pathway and further promoted MEK/ERK signaling which provided neuroprotective effects against epilepsy, status epilepticus, and neurodegenerative diseases. The gene discussed is MAP2K7; the disease is epilepsy.